Vifor Pharma has named Dario Eklund as their head of international business operations.
Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing and the Gintuit business unit.
Prior to that, he was general manager of Switzerland for Aventis Pharma, until its 2004 merger with Sanofi, and earlier in his career he held a number of commercial and management roles for Novartis.
Eklund will report directly to Vifor Pharma CEO Søren Tulstrup and will be based at company’s headquarters in Zurich, Switzerland.
Meanwhile, Vifor has also appointed Abdul Mullick to the position of head of global marketing. His previous roles include VP and general manager of endocrinology and cardiology in the rare diseases division of Sanofi in Boston, where he led the US and international operations.